Canadian JAMP Pharma Group Gets Involved - Donating one million doses of hydroxychloroquine to hospitals to help combat COVID-19

JAMP Pharma Group, a Canadian pharmaceutical company, announced today that it is donating one million doses of hydroxychloroquine to Canadian hospitals, a drug that is normally used to treat malaria and rheumatoid arthritis and which could potentially be useful in treating hospitalized patients infected with the COVID-19 virus.

NewsGuest UserMarch 23, 2020COVID19, Coronavirus, JAMP Pharma Group, JAMP Pharma, Pharma